Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jun;5(3):138-44.
doi: 10.1111/j.1747-4949.2010.00421.x.

Metabolic syndrome increases carotid artery stiffness: the Northern Manhattan Study

Affiliations

Metabolic syndrome increases carotid artery stiffness: the Northern Manhattan Study

David Della-Morte et al. Int J Stroke. 2010 Jun.

Abstract

Background: Arterial stiffness, an intermediate pre-clinical marker of atherosclerosis, has been associated with an increased risk of stroke and cardiovascular disease. The metabolic syndrome and its components are established cardiovascular disease risk factors and may also increase arterial stiffness; however, data regarding this are limited.

Aim: The goal of this study was to determine the association between the metabolic syndrome and carotid artery stiffness in an elderly multi-ethnic cohort.

Methods: Carotid artery stiffness was assessed by carotid ultrasound as part of the Northern Manhattan Study, a prospective population-based cohort of stroke-free individuals. Carotid artery stiffness was calculated as [ln(systolic BP/diastolic BP)/strain], where strain was [(systolic diameter-diastolic diameter)/diastolic diameter]. Metabolic syndrome was defined by the National Cholesterol Education Program: Adult Treatment Panel III criteria. LogSTIFF was analysed as the dependent variable in linear regression models, adjusting for demographics, education, current smoking, presence of carotid plaque and intima-media thickness.

Results: Carotid artery stiffness was analysed in 1133 Northern Manhattan Study subjects (mean age 65 +/- 9 years; 61% women; 58% Hispanic, 22% Black and 20% Caucasian). The prevalence of the metabolic syndrome was 49%. The mean LogSTIFF was 2.01 +/- 0.61 among those with the metabolic syndrome and 1.90 +/- 0.59 among those without the metabolic syndrome (P=0.003). The metabolic syndrome was significantly associated with increased logSTIFF in the final adjusted model (parameter estimate beta=0.100, P=0.01). Among individual metabolic syndrome components, waist circumference and elevated blood pressure were most significantly associated with a mean increase in logSTIFF (P<0.01).

Conclusion: The metabolic syndrome is significantly associated with increased carotid artery stiffness in a multiethnic population. Increased carotid artery stiffness may, in part, explain a high risk of stroke among individuals with the metabolic syndrome.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: All authors report no conflicts of interest.

Figures

Figure 1
Figure 1
A. B and M-mode image of the CCA diameter change during the cardiac cycles B. M-mode tracing of the CCA diameter during the cardiac cycle
Figure 2
Figure 2
Figure 2A. Metabolic syndrome components and gender The numbers express in percentage indicate the prevalence of Metabolic Syndrome components in the overall patients. Figure 2B. Metabolic syndrome components and race-ethnicity BP indicates blood pressure ≥130/85 mm Hg; FBS indicates fasting blood sugar ≥110 mg/dL; Waist indicates waist circumference >40.8” in men and >35.2” in women; Trig. Indicates triglycerides ≥150 mg/dL; HDL indicates high-density lipoprotein <40 mg/dL in men and <50 mg/dL in women.

References

    1. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA. 2002;287:356–359. - PubMed
    1. Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Final report. Circulation. 2002;106:3143–3421. - PubMed
    1. Rundek T, White H, Boden-Albala B, Jin Z, Elkind MS, Sacco RL. The metabolic syndrome and subclinical carotid atherosclerosis: the Northern Manhattan Study. J Cardiometab Syndr. 2007;2:24–29. - PubMed
    1. Ninomiya JK, L’Italien G, Criqui MH, Whyte JL, Gamst A, Chen RS. Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey. Circulation. 2004;109:42–46. - PubMed
    1. Najarian RM, Sullivan LM, Kannel WB, Wilson PW, D’Agostino RB, Wolf PA. Metabolic syndrome compared with type 2 diabetes mellitus as a risk factor for stroke: the Framingham Offspring Study. Arch Intern Med. 2006;166:106–111. - PubMed

Publication types